Synthesis of Antitumor Lycorines
J . Org. Chem., Vol. 61, No. 5, 1996 1653
20.5); 397 (16); 231 (32); 154 (100). Anal. for C21H19NO7
Calcd: C, 63.47; H, 4.82; N, 3.53. Found: C, 63.21; H, 4.90;
N, 3.49. Ethyl 6-(3-butynyloxy)-8,9-dimethoxy-3-oxo-3H-py-
ran[2,3-c]isoquinoline-2-carboxylate (8a ) was also isolated (31
mg, 46%). Mp 235-237 °C (C2H5OH). 1H NMR (CDCl3) δ 9.08
(s, 1 H); 7.56 (s, 1 H); 7.38 (s, 1 H); 4.73 (t, J ) 6.6 Hz, 2 H);
4.44 (q, J ) 7.1 Hz, 2 H); 4.11 (s, 3 H); 4.03 (s, 3 H); 2.83 (dt,
J ) 6.6, 2.7 Hz, 2 H); 2.05 (t, J ) 2.7 Hz, 1 H); 1.43 (t, J ) 7.1
Hz, 3 H). 13C NMR (CDCl3) δ 164.5; 162.8; 158.2; 157.0; 155.3;
149.8; 145.1; 131.5; 113.2; 112.1; 104.2; 101.3; 100.7, 80.0; 70.2;
at atmospheric pressure, and the flask containing the white
solid residue was evacuated and filled with argon twice before
being heated at 220 °C (external temperature, sand bath) until
5 min after the solid melted. The residue was chromato-
graphed (SiO2, CH2Cl2) to afford imide 14 (249 mg, 79%) as a
white solid. Mp 171-176 °C (sublimed). 1H NMR (CDCl3) δ
7.56 (s, 1 H); 6.66 (s, 1 H); 6.07 (s, 2 H); 4.16 (t, J ) 7.3 Hz, 2
H); 3.94 (s, 2 H); 2.55 (dt, J ) 7.3, 2.6 Hz, 2H); 1.97 (t, J ) 2.6
Hz, 1 H). 13C NMR (CDCl3) δ 169.7; 163.9; 152.66; 147.8;
130.3; 119.3; 107.9; 106.4; 102.1; 80.7; 69.7; 38.2; 36.4; 17.5.
UV (C2H5OH), λmax: 208, 228, 272, 310 nm. LRMS, m/ z (%):
257 (M+, 77.8); 218 (24.9); 205 (34.7); 189 (100). HRMS for
C14H11NO4. Calcd: 257.0688. Found: 257.0691.
4-(An ilin om et h ylen e)-2-(3-b u t yn yl)-6,7-(m et h ylen e-
d ioxy)-1,2,3,4-tetr a h yd r oisoqu in olin e-1,3-d ion e (15). To
a solution of imide 14 (45 mg, 0.175 mmol) in DMF (3 mL)
containing one drop of acetic acid, solutions of trimethyl
orthoformate (56 mg, 0.526 mmol) and aniline (50 mg, 0.526
mmol) in DMF (1 mL each) were successively added. The
resulting mixture was heated at 90 °C for 3.5 h, concentrated
65.7; 61.9; 56.5; 56.2; 19.1; 14.3. IR (KBr): 1740, 1715 cm-1
.
UV (C2H5OH), λmax: 226, 252, 276, 282, 318, 392 nm. LRMS,
m/ z (%): 397 (M+, 30); 167 (100). HRMS for C21H19NO7.
Calcd: 397.1162. Found: 397.1161. Treatment of a solution
of 8a (10 mg, 0.025 mmol) in C2H5OH (2 mL) with 36% HCl (1
mL) for 1 h at 70 °C, removal of the ethanol, partition of the
mixture between H2O and CH2Cl2, and chromatography (1%
CH2Cl2-MeOH) recovered 6a (7 mg, 80%).
Rea ction of 6b w ith 7. Pyrone 6b (125 mg, 0.380 mmol)
in DMF (4 mL) was reacted with KOt-Bu (54 mg, 0.408 mmol)
and tosylate 7 (225 mg, 1 mmol) for 1.5 h, as described above,
to afford 5-(3-butynyl)-8,9-(methylenedioxy)-3,6-dioxo-5,6-di-
hydro-3H-pyran[2,3-c]isoquinoline-2-carboxylate (9b) (45 mg,
31%) and 6-(3-butynyloxy)-8,9-(methylenedioxy)-3-oxo-3H-py-
ran[2,3-c]isoquinoline-2-carboxylate (8b) (50 mg, 35%). Da ta
for 9b. Mp 210-211 °C (acetone). 1H NMR (CDCl3-CD3OD
50:1) δ 8.94 (s, 1 H); 7.51 (s, 1 H); 7.40 (s, 1 H); 6.14 (s, 2 H);
4.63 (t, J ) 6.6 Hz, 2 H); 4.39 (q, J ) 7.1 Hz, 2 H); 2.76 (dt, J
) 6.6, 2.6 Hz, 2 H); 2.04 (t, J ) 2.6 Hz, 1 H); 1.39 (t, J ) 7.1
Hz, 3 H). 13C NMR (CDCl3-CD3OD 50:1) δ 163.8; 162.9; 158.0;
157.0; 153.8; 148.2; 145.2; 133.4; 113.3; 113.0; 102.5; 102.1;
101.7; 98.7; 79.9; 70.1; 65.7; 61.8; 18.9; 14.1. IR (KBr): 1775,
1735, 1675 cm-1. UV (C2H5OH), λmax: 226, 242, 284, 392 nm.
LRMS, m/ z (%): 381 (M+, 100); 329 (86); 301 (59). HRMS for
C20H15NO7. Calcd: 381.0848. Found: 381.0844. Anal. for
C20H15NO7. Calcd: C, 62.99; H, 3.96; N, 3.67. Found: C,
62.72; H, 3.81; N, 3.97. Da ta for 8b. Mp 220-221 °C
(acetone). 1H NMR (CDCl3) δ 9.02 (s, 1 H); 7.60 (s, 1 H); 7.47
(s, 1 H); 6.19 (s, 2 H); 4.70 (t, J ) 6.6 Hz, 2 H); 4.44 (q, J ) 7.1
Hz, 2 H); 2.80 (dt, J ) 6.6, 2.6 Hz, 2 H); 2.06 (t, J ) 2.6 Hz, 1
H); 1.45 (t, J ) 7.1 Hz, 3 H). 13C NMR (CDCl3) δ 163.8; 162.8;
158.2; 156.8; 153.7; 148.2; 144.9; 133.5; 113.4; 102.2; 101.7;
under reduced pressure, and treated with CH3
OH (3 mL). The
resulting suspension was filtered to afford enamine 15 (36 mg)
as a yellow solid, and the filtrate was concentrated to dryness
and chromatographed (5% ethyl ether-CH2Cl2), yielding ad-
ditional 15 (20 mg, 89% yield). Mp 214-216 °C (C2H5OH),
bright yellow crystals. 1H NMR (CDCl3) δ 12.29 (bd, J ) 12
Hz, 1 H); 8.25 (d, J ) 12.5 Hz, 1 H); 7.63 (s, 1 H); 7.45-7.39
(m, 2 H); 7.26-7.16 (m, 3 H); 6.99 (s, 1 H); 6.05 (s, 2 H); 4.32
(t, J ) 7.3 Hz, 2 H); 2.65-2.60 (m, 2 H); 1.99 (bs, 1 H).
13C
NMR (CDCl3) δ 166.1; 162.9; 153.0; 146.0; 142.9; 139.4; 132.1;
130.0; 125.0; 117.3; 115.9; 107.3; 101.8; 97.0; 96.6; 81.2; 69.6;
38.2; 17.6. UV (C2
H OH), λmax: 232, 312, 402 nm. LRMS, m/ z
5
(%): 360 (M+, 100); 308 (67); 292 (31); 291 (20). HRMS for
C21H16N2O4. Calcd: 360.1110. Found: 360.1111. Anal. for
C21H16N2O4. Calcd: C, 69.99; H, 4.48; N, 7.77. Found: C,
69.48; H, 4.54; N, 7.62.
E t h yl 5-(3-Bu t yn yl)-8,9-(m et h ylen ed ioxy)-3,6-d ioxo-
5,6-d ih yd r o-3H -p yr a n [2,3-c]isoq u in olin e-2-ca r b oxyla t e
(9b). F r om en a m in e 15. KOt-Bu (34 mg, 0.3 mmol) was
added to a solution of 15 (72 mg, 0.2 mmol) and ethyl
cyanoacetate (34 mg, 0.3 mmol) in dry DMF (2 mL), and the
mixture was stirred at 90 °C for 1 h. HCl (36%, 1 mL) was
added, stirring was continued at rt for 3 h, and the resulting
orange suspension was filtered. The solid was redissolved in
hot methanol, HCl was added to pH 4, and stirring was
continued overnight. The solvent was removed under reduced
pressure, water (2 mL) was added, and the resulting suspen-
sion was extracted with CH2Cl2 (3 × 3 mL). The organic phase
was dried with Na2SO4 and was chromatographed (4% ethyl
ether-CH2Cl2) to afford pyrone 9b (30 mg, 76%). F r om im id e
14. A mixture of imide 14 (26 mg, 0.10 mmol) and ethoxym-
ethylene diethyl malonate (16a ) (24 mg, 0.11 mmol) was sealed
in a tube in an argon atmosphere and heated for 10 min at
200 °C (external temperature, sand bath). Chromatography
of the mixture (2:8 ethyl ether-CH2Cl2) then afforded pyrone
9b (23 mg, 60%).
98.7; 80.0; 70.1; 65.7; 61.8; 19.0; 14.2. IR (film): 1755 cm-1
.
UV (C2H5OH), λmax: 222, 254, 268, 330, 382 nm. LRMS, m/ z
(%): 381 (M+, 35); 329 (35); 280 (85); 229 (55); 69 (100). HRMS
for C20H15NO7. Calcd: 381.0848. Found: 381.0847.
3-Bu tyn -1-a m in e Hyd r och lor id e (12). (i) NaN3 (5.62 g,
117.19 mmol) was added to a solution of 3-butynyl p-toluene-
sulfonate (7)11 (5.25 g, 23.44 mmol) in dry DMF (30 mL), and
the resulting suspension was stirred for 24 h. The mixture
was partitioned between H2O (100 mL) and ethyl ether (100
mL), the aqueous phase was extracted with ethyl ether (50
mL), and the combined organic phase was thoroughly washed
with H2O (5 × 25 mL), dried with MgSO4, and concentrated
to remove most of the ether. The resulting clear liquid,
containing 3-butynyl azide, was used in step ii without further
purification. (ii) The reaction crude obtained as above was
dissolved in CH3OH (75 mL), SnCl2‚2H2O (10.58 g, 46.88
mmol) was added, and stirring at rt was kept up for 24 h. The
solvent was evaporated at reduced pressure, the residue was
dissolved in 10% aqueous NaOH, and this solution was
extracted with CH2Cl2 (5 × 40 mL). The combined organic
phase was dried with Na2SO4, a saturated solution of HCl in
ethyl ether (20 mL) was added, and the resulting precipitate
was collected by filtration, affording 12 (2.14 g) as a white solid;
the filtrates were concentrated to dryness to obtain additional
12 (310 mg, quantitative yield). Spectroscopic data were
identical with those reported in the literature.12c
5-(3-Bu tyn yl)-2-m eth oxy-8,9-(m eth ylen ed ioxy)-5,6-d i-
h yd r o-3H-p yr a n [2,3-c]isoqu in olin e-3,6-d ion e (9c). A so-
lution of methyl 3-(dimethylamino)-2-methoxyacrylate (16b)17
(48 mg, 300 mmol) in CH2Cl2 (0.5 mL) was added to imide 14
(51 mg, 0.198 mmol). The mixture was heated for 10 min at
180 °C (external temperature, sand bath) under a strong
current of argon. The crude residue was chromatographed (4%
ethyl ether-CH2
Cl2) to afford pyrone 9c (60 mg, 90%) as a
white solid. Mp 227-228 °C (CH2Cl2-hexanes). 1H NMR
(DMSO-d6) δ 7.81 (s, 1 H); 7.70 (s, 1 H); 7.51 (s, 1 H); 6.20 (s,
2 H); 4.24 (t, J ) 7.2 Hz, 2 H); 3.85 (s, 3 H); 2.87 (t, J ) 2.4
Hz, 1 H); 2.60 (m, 2 H). 13C NMR (DMSO-d6) δ 158.4; 154.7;
153.0; 147.3; 143.8; 139.7; 129.3; 117.3; 113.6; 105.2; 102.6;
100.9; 94.2; 80.7; 73.1; 57.0; 17.2. UV (C2H5OH), λmax: 226,
260, 278, 360 nm. LRMS, m/ z (%): 339 (M+, 100); 296 (63);
244 (79); 177 (28). HRMS for C18H13NO6. Calcd: 339.0743.
Found: 339.0736.
2-(3-Bu t yn yl)-6,7-(m e t h yle n e d ioxy)-1,2,3,4-t e t r a h y-
d r oisoqu in olin e-1,3-d ion e (14). Hydrochloride 12 (650 mg,
6.16 mmol) was dissolved in 10% aqueous NaOH (5 mL), the
solution was extracted with CH2Cl2 (3 × 2 mL), and the
combined organic phase was dried over Na2SO4. The solution
of 3-butyn-1-amine so obtained was added at rt to a solution
of anhydride 1313 (258 mg, 1.22 mmol) in CH2Cl2 (5 mL), and
stirring was continued for 20 h. The solvent was distilled off
Cycliza tion of P yr on es 9. Gen er a l P r oced u r e.
A
solution of pyrone 9 in nitrobenzene is heated under argon
until the starting material has been consumed (TLC). The